Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00806650
Recruitment Status : Completed
First Posted : December 11, 2008
Last Update Posted : December 8, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
City of Hope Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 15, 2017
  Study Completion Date : November 15, 2017